Research and Markets has announced the addition of the "Deep Vein Thrombosis Pipeline Highlights - 2017" drug pipelines to their offering.

This report, Deep Vein Thrombosis Pipeline Highlights - 2017, provides most up-to-date information on key pipeline products in the global Deep Vein Thrombosis market. It covers emerging therapies for Deep Vein Thrombosis in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:

The report provides Deep Vein Thrombosis pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:

The report provides Deep Vein Thrombosis pipeline products by their dominant mechanism of action. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

Company:

The report provides Deep Vein Thrombosis pipeline products by the company.

Short-term Launch Highlights:

Find out which Deep Vein Thrombosis pipeline products will be launched in the US and Ex-US till 2020.

Key Topics Covered:

1. Deep Vein Thrombosis Pipeline by Stages

2. Deep Vein Thrombosis Pipeline by Drug Class

3. Deep Vein Thrombosis Pipeline by Company

4. Deep Vein Thrombosis Phase 3 Clinical Trial Insights

5. Deep Vein Thrombosis Phase 2 Clinical Trial Insights

6. Deep Vein Thrombosis Phase 1 Clinical Trial Insights

7. Deep Vein Thrombosis Preclinical Research Insights

8. Deep Vein Thrombosis Discovery Stage Insights

9. Appendix

For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/s2z44x/deep_vein